COVID-19 Reactogenicity
Clinical trial NCT07051031 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07051031
- Sponsor
- Marcel Curlin
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2026-06-14
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.